For an accessible version of this Press Release, please visit www.tevapharm.com
Q2 2024 revenues of $4.2 billion reflecting an increase of 7% in U.S. dollars or 11% in local currency terms compar...
Second quarter consolidated revenue declined 16% on lower industry demand
Second quarter diluted EPS at $0.34; adjusted diluted EPS at $0.38 ($0.52 in the second quarter of 2023)
Results reflect c...
Unlock Cavli C11QM's Efficient Compute, Versatile OS & SDK, and In-Built GNSS capabilities
SAN JOSE, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Cavli Wireless, one of the first truly '...
Bitvavo will use Nasdaq Market Surveillance to detect and investigate suspected market abuse
Enhanced capability marks a major milestone in the development of the Bitvavo platform
Supports early c...
ADELAIDE, Australia and WAKE FOREST, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech compani...
